Share on StockTwits

Investment analysts at Chardan Capital began coverage on shares of Medical Transcription Billing Corp (NASDAQ:MTBC) in a note issued to investors on Wednesday, reports. The firm set a “buy” rating and a $11.00 price target on the stock. Chardan Capital’s price target indicates a potential upside of 232.33% from the stock’s previous close.

Medical Transcription Billing Corp (NASDAQ:MTBC) opened at 3.31 on Wednesday. Medical Transcription Billing Corp has a 52-week low of $3.19 and a 52-week high of $5.00. The stock’s 50-day moving average is $3. and its 200-day moving average is $3.. The company’s market cap is $36.4 million.

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.